BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garcia-Saenz-de-Sicilia M, Sanchez-Avila F, Chavez-Tapia NC, Lopez-Arce G, Garcia-Osogobio S, Ruiz-Cordero R, Tellez-Avila FI. PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis. World J Gastroenterol 2010; 16(46): 5869-5873 [PMID: 21155009 DOI: 10.3748/wjg.v16.i46.5869]
URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5869.htm
Number Citing Articles
1
Tamás Janka, Tamás Tornai, Brigitta Borbély, Dávid Tornai, István Altorjay, Mária Papp, Zsuzsanna Vitális. Deleterious effect of proton pump inhibitors on the disease course of cirrhosisEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 257 doi: 10.1097/MEG.0000000000001499
2
Elaine A. G. Lo, Kyle J. Wilby, Mary H. H. Ensom. Use of Proton Pump Inhibitors in the Management of Gastroesophageal VaricesAnnals of Pharmacotherapy 2015; 49(2): 207 doi: 10.1177/1060028014559244
3
Zhao-Ni Lin, Yong-Qing Zuo, Peng Hu. Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver FailureHepatitis Monthly 2014; 14(3) doi: 10.5812/hepatmon.16258
4
Jolene F Siple, Jessica M Morey, Tracy E Gutman, Kathy L Weinberg, Peggie D Collins. Proton Pump Inhibitor Use and Association with Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and AscitesAnnals of Pharmacotherapy 2012; 46(10): 1413 doi: 10.1345/aph.1R174
5
D. K. Li, P. Yan, A-B. Abou-Samra, R. T. Chung, A. A. Butt. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVESAlimentary Pharmacology & Therapeutics 2018; 47(2): 246 doi: 10.1111/apt.14391
6
Tsung-Hsing Hung, Hsing-Feng Lee, Chih-Wei Tseng, Chih-Chun Tsai, Chen-Chi Tsai. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleedingClinics and Research in Hepatology and Gastroenterology 2018; 42(4): 353 doi: 10.1016/j.clinre.2017.11.011
7
Yudai Koya, Michihiko Shibata, Tatsuyuki Watanabe, Shinsuke Kumei, Koichiro Miyagawa, Shinji Oe, Yuichi Honma, Keiichiro Kume, Ichiro Yoshikawa, Masaru Harada. Influence of gastroesophageal flap valve on esophageal variceal bleeding in patients with liver cirrhosisDigestive Endoscopy 2021; 33(1): 100 doi: 10.1111/den.13685
8
Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Junji Ueda, Eiji Uchida. Risk Factors for Bleeding Esophagogastric VaricesJournal of Nippon Medical School 2013; 80(4): 252 doi: 10.1272/jnms.80.252
9
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and ConsClinical Drug Investigation 2017; 37(7): 587 doi: 10.1007/s40261-017-0519-y
10
Darrick K. Li, Raymond T. Chung. Use of proton pump inhibitors in chronic liver diseasesClinical Liver Disease 2017; 10(6): 148 doi: 10.1002/cld.678
11
Lung-Yi Mak, James Fung. Proton pump inhibitors in chronic liver disease: accomplice or bystander?Hepatology International 2020; 14(3): 299 doi: 10.1007/s12072-020-10033-1
12
Mihajlo Gjeorgjievski, Mitchell S Cappell. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapyWorld Journal of Hepatology 2016; 8(4): 231-262 doi: 10.4254/wjh.v8.i4.231
13
Hassan Ghoz, Payal Patel, Fernando Stancampiano, Sheetal Patel, Erin A. Fox, Mohammad B. Yousaf, Mohamed Omer, Michael G. Heckman, Matthew R. Spiegel, William C. Palmer. Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort studyEuropean Journal of Gastroenterology & Hepatology 2020; 32(12): 1571 doi: 10.1097/MEG.0000000000001905
14
H. L. Cole, S. Pennycook, P. C. Hayes. The impact of proton pump inhibitor therapy on patients with liver diseaseAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1213 doi: 10.1111/apt.13827
15
Antonio Picardi, Umberto Vespasiani-Gentilucci. Proton pump inhibitor prescription abuse and sepsis in cirrhosisWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 1-4 doi: 10.4292/wjgpt.v7.i1.1